You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NTRK1

Showing 26 - 50 of 86
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancers With NTRK, ROS1, or ALK Gene Fusions Trial in San Diego (Entrectinib)

No longer available
  • Cancers With NTRK, ROS1, or ALK Gene Fusions
  • San Diego, California
    1-844-Startrk (782-7875)
Apr 24, 2019

Biliary Tract Tumors, Gastric Cancer, Esophageal Squamous Cell Carcinoma Trial in Beijing (FGFR Inhibitor, IDH1 Inhibitor, HER2

Unknown status
  • Biliary Tract Neoplasms
  • +8 more
  • FGFR Inhibitor, IDH1 Inhibitor, HER2 Inhibitor, PARP Inhibitor, BRAF Inhibitor, MEK Inhibitor, ICIs, EGFR-TKIs, NTRK-TKI, and et. al.
  • Other Therapy
  • Beijing, Beijing, China
    Peking University Cancer Hospital
Oct 8, 2020

Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +44 more
  • Biopsy
  • +23 more
  • Birmingham, Alabama
  • +166 more
Feb 2, 2023

A Retro-/Prospective, Non-interventional, Cohort Study in Adult

Active, not recruiting
  • Solid Tumor, Adult
  • +2 more
    • Amiens, France
    • +3 more
    Jul 22, 2022

    Locally Advanced or Recurrent/Metastatic Salivary Gland Carcinoma, Neoadjuvant or Conversion Therapy, Precision Therapy Trial in

    Recruiting
    • Locally Advanced or Recurrent/Metastatic Salivary Gland Carcinoma
    • +2 more
    • Beijing, Beijing, China
    • +1 more
    Nov 21, 2023

    Thyroid Carcinoma

    Recruiting
    • Differentiated Thyroid Carcinoma
    • Medullary Thyroid Carcinoma
    • Immunohistochemistry (IHC)
    • +2 more
    • L'Hospitalet De Llobregat, Barcelona, Spain
    • +11 more
    Mar 22, 2022

    Learn More About NTRK Gene Fusion Positive in Solid Tumor in

    Not yet recruiting
    • Advanced or Recurrent Solid Tumor Harboring an NTRK Gene Fusion
    • No Drug
    • Multiple Locations, Japan
      Many Locations
    Mar 20, 2023

    Locally Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial in Houston (Larotrectinib Sulfate)

    Recruiting
    • Locally Advanced Malignant Solid Neoplasm
    • Metastatic Malignant Solid Neoplasm
    • Larotrectinib Sulfate
    • Houston, Texas
      M D Anderson Cancer Center
    Apr 18, 2022

    NTRK Gene Fusion - Positive Advanced or Recurrent Solid

    Recruiting
    • Advanced or Recurrent Solid Tumor Harboring an NTRK Gene Fusion
    • Larotrectinib (Vitrakvi, BAY2757556)
    • Multiple Locations, Japan
      Many locations
    Jan 20, 2023

    Metastasis, Tumor Trial in HangZhou (BPI-28592)

    Recruiting
    • Metastasis, Neoplasm
    • HangZhou, Zhejiang, China
      Sir Run Run Shaw Hospital (SRRSH), affiliated with the Zhejiang
    Mar 21, 2022

    Obesity, Child Trial (sequencing of a panel of 14 genes in leptin melanocortin pathway)

    Not yet recruiting
    • Obesity, Child
    • sequencing of a panel of 14 genes in leptin melanocortin pathway
    • (no location specified)
    Jul 3, 2023

    Advanced Solid Tumors Harboring NTRK Fusion, Primary CNS Tumors Harboring NTRK Fusion Trial in Guangzhou (ICP-723)

    Recruiting
    • Advanced Solid Tumors Harboring NTRK Fusion
    • Primary Central Nervous System Tumors Harboring NTRK Fusion
    • Guangzhou, Guangdong, China
      Sun Yat-Sen University Cancer Center
    Feb 16, 2023

    Cervical/Supraclavicular Metastasis From Non-small-cell Lung

    Recruiting
    • Lung Cancer Metastatic
    • Needle or forceps biopsy of cervical and/or supraclavicular lymph nodes
    • Needle, forceps or surgical biopsy of any lesion other than cervical and/or supraclavicular lymph nodes
    • Roma, Italy
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS
    Jan 23, 2023

    NSCLC Trial in United States (Alectinib, Entrectinib, Vemurafenib)

    Recruiting
    • Non-small Cell Lung Cancer
    • Duarte, California
    • +24 more
    Feb 2, 2023

    NSCLC Stage IV, HIV, HBV Trial in Verona (Nivolumab and Ipilimumab)

    Not yet recruiting
    • NSCLC Stage IV
    • +4 more
    • Nivolumab and Ipilimumab
    • Verona, Veneto/Verona, Italy
      Centro Ricerche Cliniche
    Oct 26, 2022

    Advanced Malignant Solid Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Trial

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +30 more
    • Larotrectinib Sulfate
    • Birmingham, Alabama
    • +123 more
    Aug 23, 2022

    NTRK Gene Fusion in Adult Brain Tumours

    Not yet recruiting
    • Glioma
    • Glioma data collection
    • Brain metastasis data collection
    • Marseille, France
      Hôpital Privé Clairval
    Aug 24, 2021

    China With Non-Small-Cell Lung Cancer That is Unable to be

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
      • (no location specified)
      May 16, 2023

      Cancer (With or Without Metastasis) Trial in Houston (TSN084)

      Recruiting
      • Cancer (With or Without Metastasis)
      • Houston, Texas
        MD Anderson Cancer Center
      Apr 22, 2022

      Lung Cancer Trial in Angers, St Herblain (Metastasis biopsy)

      Not yet recruiting
      • Lung Cancer
      • Metastasis biopsy
      • Angers, France
      • +1 more
      Jul 26, 2022

      Advanced Solid Tumor Trial in Changsha (IBI363)

      Not yet recruiting
      • Advanced Solid Tumor
      • Changsha, Hunan, China
        Yongchang Zhang
      Oct 12, 2023

      Resistance-associated Mutations in Metastatic Lung Cancer

      Recruiting
      • Lung Cancer
      • Liquid biopsy
      • Monza, MB, Italy
        Fondazione IRCCS San Gerardo dei Tintori
      Oct 10, 2023

      Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Portland (Decitabine and

      Not yet recruiting
      • Acute Myeloid Leukemia
      • +2 more
      • Decitabine and Cedazuridine
      • +2 more
      • Portland, Oregon
        OHSU Knight Cancer Institute
      May 25, 2022

      NSCLC Trial in Guangzhou (Avitinib Maleate, Afatinib, Crizotinib)

      Recruiting
      • Carcinoma, Non-Small-Cell Lung
      • Avitinib Maleate
      • +13 more
      • Guangzhou, Guangdong, China
        Guangdong Lung Cancer Institute, Guangdong Provincial People's H
      Dec 3, 2022

      Advanced Solid Tumor Trial in Shanghai (FCN-011)

      Recruiting
      • Advanced Solid Tumor
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Aug 16, 2021